Becker's Healthcare October 21, 2021
Maia Anderson

Six deals and acquisitions completed by drugmakers since the end of July, as reported by Becker’s Hospital Review:

  1. Merck plans to acquire Acceleron Pharma for about $11.5 billion to expand its rare disease drug portfolio.
  2. Sanofi will acquire New York City-based drugmaker Kadmon for $1.9 billion.
  3. Pfizer entered into a definitive agreement to buy Canadian cancer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas
New AI drug discovery powerhouse Xaira rises with $1B in funding
Moderna turns to AI to change how its employees work

Share This Article